EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review of Extracellular Vesicles in COVID‐19 Diagnosis, Treatment, and Prevention

Peng Su, Yuchen Wu, Feng Xie, Qinghui Zheng, Long Chen, Zhuang Liu, Xuli Meng, Fangfang Zhou iD, Long Zhang

Advanced Science · 2023

DOI: 10.1002/advs.202206095 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, 2023. Verfasst von Peng Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Zhejiang Provincial People's Hospital, Hangzhou, 310014, P. R. China. Hauptthemen laut MEDLINE: COVID-19, Extracellular Vesicles. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 261 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of China, Chinese National Natural Science Funds, National Science Fund for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2019 novel coronavirus disease (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is ongoing, and has necessitated scientific efforts in disease diagnosis, treatment, and prevention. Interestingly, extracellular vesicles (EVs) have been crucial in these developments. EVs are a collection of various nanovesicles which are delimited by a lipid bilayer. They are enriched in proteins, nucleic acids, lipids, and metabolites, and naturally released from different cells. Their natural material transport properties, inherent long‐term recycling ability, excellent biocompatibility, editable targeting, and inheritance of parental cell properties make EVs one of the most promising next‐generation drug delivery nanocarriers and active biologics. During the COVID‐19 pandemic, many efforts have been made to exploit the payload of natural EVs for the treatment of COVID‐19. Furthermore, strategies that use engineered EVs to manufacture vaccines and neutralization traps have produced excellent efficacy in animal experiments and clinical trials. Here, the recent literature on the application of EVs in COVID‐19 diagnosis, treatment, damage repair, and prevention is reviewed. And the therapeutic value, application strategies, safety, and biotoxicity in the production and clinical applications of EV agents for COVID‐19 treatment, as well as inspiration for using EVs to block and eliminate novel viruses are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Extracellular VesiclesAnimalsHumansSARS-CoV-2PandemicsCOVID-19 Drug TreatmentCOVID-19 Testing

Stichwörter der Autor:innen

coronavirus disease 2019diagnosisdrug deliveryextracellular vesiclesneutralization traps

Autor:innen und Institutionen

  • Department of Breast Surgery, Zhejiang Provincial People's Hospital, Hangzhou, 310014, P. R. China.
  • Institutes of Biology and Medical Science, Soochow University, Suzhou, 215123, P. R. China.
  • Department of Clinical Medicine, The First School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, P. R. China.
  • Center for Translational Medicine, The Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang, Jiangsu, 215600, China.
  • Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.
  • MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, P. R. China.

ORCID-Profile: Fangfang Zhou

Förderung

  • Ministry of Science and Technology of China
  • Chinese National Natural Science Funds
  • National Science Fund for Distinguished Young Scholars
  • Zhejiang Natural Science Fund
  • Jiangsu Provincial Distinguished Young Scholars award
  • Key Project of University Natural Science Foundation of Jiangsu Province
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province

Zitieren

APA

Su, P., Wu, Y., Xie, F., Zheng, Q., Chen, L., Liu, Z., Meng, X., Zhou, F., & Zhang, L. (2023). A Review of Extracellular Vesicles in COVID‐19 Diagnosis, Treatment, and Prevention. Advanced Science. https://doi.org/10.1002/advs.202206095

Vancouver

Su P, Wu Y, Xie F, Zheng Q, Chen L, Liu Z, et al. A Review of Extracellular Vesicles in COVID‐19 Diagnosis, Treatment, and Prevention. Advanced Science. 2023. doi:10.1002/advs.202206095

BibTeX
@article{Su2023,
  author = {Su, Peng and Wu, Yuchen and Xie, Feng and Zheng, Qinghui and Chen, Long and Liu, Zhuang and Meng, Xuli and Zhou, Fangfang and Zhang, Long},
  title = {A Review of Extracellular Vesicles in COVID‐19 Diagnosis, Treatment, and Prevention},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202206095}
}
Kostenlos starten →